Abstract | OBJECTIVE: DESIGN: Computer-based econometric modeling. METHODS: The cost effectiveness of laser photocoagulation therapy was compared with the natural course of subfoveal choroidal neovascularization. The model applied long-term visual data from previous clinical trials, utility analysis (which reflects patient perceptions of quality of life associated with a health state), decision analysis with Markov modeling, and the economic principles of present value analysis with discounting to account for the time value of money. DATABASE: INTERVENTION: MAIN OUTCOME MEASURE: Cost per quality-adjusted life-year ($/QALY gained) associated with laser therapy. RESULTS:
Laser photocoagulation therapy for subfoveal choroidal neovascularization, as compared with no treatment, resulted in a mean gain of 0.257 QALYs per treated patient. Using a yearly discount rate of 3% to account for the time value of money and inflation, the resultant $/QALY gained was $5629. Sensitivity analysis used in the cost-effectiveness analysis resulted in a $/QALY gained of $4974 with no gained discount rate and $11,633 with a yearly discount rate of 10%. CONCLUSIONS: The incremental expense of laser therapy for the treatment of subfoveal choroidal neovascularization appears to be highly cost effective. The result, which takes into account patient preference-based utility data, compares quite favorably with other interventional therapies across different medical specialties.
|
Authors | G C Brown, M M Brown, S Sharma, H Brown, W Tasman |
Journal | Ophthalmology
(Ophthalmology)
Vol. 107
Issue 7
Pg. 1374-80
(Jul 2000)
ISSN: 0161-6420 [Print] United States |
PMID | 10889115
(Publication Type: Comparative Study, Journal Article)
|
Topics |
- Aged
- Choroidal Neovascularization
(economics, surgery)
- Cost-Benefit Analysis
- Decision Support Techniques
- Fovea Centralis
- Health Status
- Humans
- Laser Coagulation
(economics)
- Markov Chains
- Models, Econometric
- Quality of Life
- Visual Acuity
|